RX Daytona Plus (with ISE/without ISE); Models Nos. RX4040 (w/ISE) and RX4041 (without ISE) - Pro...
FDA Device Recall #Z-1349-2020 - Class II, December 19, 2019
Recall Summary
| Recall Number | Z-1349-2020 |
| Classification | Class II - Moderate risk |
| Date Initiated | December 19, 2019 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | Randox Laboratories, Limited |
| Location | Crumlin, N/A |
| Product Type | Devices |
| Quantity | U.S.: RX4040-2 units RX 4041-3 units |
Product Description
RX Daytona Plus (with ISE/without ISE); Models Nos. RX4040 (w/ISE) and RX4041 (without ISE) - Product Usage: A fully automated, random access, clinical chemistry analyzer complete with dedicated analyzer software. For use in clinical laboratories.
Reason for Recall
Software version UI2550642107 for the RX Daytona + instrument released to correct the following issues: 1) The order of samples displayed is not sequential according to SID (sample identification number) when searching the run/results screen; 2) Incorrect color flagging of IQC as "out of range."
Distribution Pattern
US Nationwide distribution including state of PR.
Lot / Code Information
Software version UI2550642107 for the RX Daytona Plus instrument.
Other Recalls from Randox Laboratories, Limited
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-1017-2025 | Class II | Randox Lipoprotein (a) - In vitro diagnostic (... | Dec 20, 2024 |
| Z-1018-2025 | Class II | Randox Lipoprotein (a) - In vitro diagnostic (I... | Dec 20, 2024 |
| Z-0414-2020 | Class II | Randox Liquid Cardiac Controls Catalogue Number... | Oct 4, 2019 |
| Z-0412-2020 | Class II | Randox Liquid Cardiac Controls Catalogue Number... | Oct 4, 2019 |
| Z-0413-2020 | Class II | Randox Liquid Cardiac Controls Catalogue Number... | Oct 4, 2019 |
Frequently Asked Questions
A software recall means the device's embedded software or firmware has a defect that could affect its performance or safety. Many software recalls are corrected through firmware updates that can be applied without physically replacing the device. For implantable devices, the update may be delivered wirelessly during a routine clinic visit. For external devices, the manufacturer may provide updated software files or replacement units. Contact your healthcare provider to determine whether your specific device and software version are affected and what action is recommended.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency, Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.